(Q67282749)

English

3.75 and 7.5 mg leuprorelin acetate depot in the treatment of advanced prostatic cancer: preliminary report. German Leuprorelin Study Group

scientific article published on 01 January 1990

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2108882

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2108882%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 September 2019

title

3.75 and 7.5 mg leuprorelin acetate depot in the treatment of advanced prostatic cancer: preliminary report. German Leuprorelin Study Group (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2108882

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2108882%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

1 reference

W Bischoff

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2108882

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2108882%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 September 2019

publication date

1 January 1990

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2108882

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2108882%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 September 2019

published in

Journal of International Medical Research

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2108882

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2108882%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 September 2019

volume

18 Suppl 1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2108882

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2108882%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 September 2019

page(s)

103-113

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2108882

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2108882%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 September 2019

Identifiers

DOI

10.1177/03000605900180S115

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2108882

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2108882%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 September 2019

PubMed publication ID

2108882

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2108882

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2108882%20AND%20SRC:MED&resulttype=core&format=json

(Q67282749)

3.75 and 7.5 mg leuprorelin acetate depot in the treatment of advanced prostatic cancer: preliminary report. German Leuprorelin Study Group

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)